Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell Ondo Insurtech (ONDO) by Steve Moore in ShareProphets
- Underperform Bunzl (BNZL) by Jefferies
- Buy British American Tobacco (BATS) by Jefferies
- Buy Severfield (SFR) by Jefferies
- Buy Plus500 Ltd (DI) (PLUS) by Jefferies
- Buy Barratt Redrow (BTRW) by Deutsche Bank
- Buy Discoverie Group (DSCV) by Deutsche Bank
- Outperform JD Sports Fashion (JD.) by RBC Capital
- Buy Persimmon (PSN) by Citi
- Buy Inchcape (INCH) by Berenberg
- Sell Poolbeg Pharma (POLB) by Hot Stock Rockets in ShareProphets
- Buy Oxford Metrics (OMG) by Tom Winnifrith in ShareProphets
- Buy Oxford Metrics (OMG) by Steve Moore in ShareProphets
- Buy Mortgage Advice Bureau (Holdings) (MAB1) by Berenberg
- Buy Filtronic (FTC) by Berenberg
- Buy Netcall (NET) by Berenberg
- Avoid Transense Technologies (TRT) by Steve Moore in ShareProphets
- Avoid eEnergy Group (EAAS) by Steve Moore in ShareProphets
- Add AstraZeneca (AZN) by Simon Watkins in The Motley Fool
- Buy Persimmon (PSN) by Harvey Jones in The Motley Fool
Poolbeg Pharma (POLB) Share Price
Health Care Sector
NOTE: This is based on 3 open tips for Poolbeg Pharma (POLB)
| Latest Bid : 6.60p | Latest Ask : 6.90p |
| High Today : 7.40p | Low Today : 6.50p |
| This Years High : 8.42p | This Years Low : 2.55p |
| Volume : 1,797,619 | MKT Cap : £33.75M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Poolbeg Pharma (POLB) Overview
Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the "one-stop shop" for Big Pharma seeking mid-stage products to license or acquire.Poolbeg Pharma (POLB) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Hot Stock Rockets | Premium Only | 2026-06-22 15:20:00 22/06/2026 | 7.53% |
| Watch | Edward Sheldon | Premium Only | 2024-05-15 09:45:00 15/05/2024 | – |
| Buy | Joanne Hart | Premium Only | 2021-08-22 14:55:00 22/08/2021 | 39.01% |
Poolbeg Pharma (POLB) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 6.60p | Latest Ask : 6.90p |
| High Today : 7.40p | Low Today : 6.50p |
| This Years High : 8.42p | This Years Low : 2.55p |
| Volume : 1,797,619 | MKT Cap : £33.75M |
Poolbeg Pharma Overview
Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the "one-stop shop" for Big Pharma seeking mid-stage products to license or acquire.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Poolbeg Pharma Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Hot Stock Rockets | Premium Only | 2026-06-22 15:20:00 22/06/2026 | 7.53% |
| Watch | Edward Sheldon | Premium Only | 2024-05-15 09:45:00 15/05/2024 | – |
| Buy | Joanne Hart | Premium Only | 2021-08-22 14:55:00 22/08/2021 | 39.01% |